ArticleCancer cell international2012

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.

Jiangning Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.